INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 452m ago
HOUSE PTR51m ago
SEC 13F51m ago
ROBINHOOD CHAIN51m ago
Public company

EXOZEXOZYMES INC.

CIK 0002010788

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score35
Connections2with evidence

EXOZ · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
PA
Perriman Damien AlanChief Commercial Officer
EXOZEXOZYMES INC.
Option exercise
M—
3,922 sh
Oct 9, 2026Oct 26, 2026
traded Oct 9, 2026
+17dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Perriman Damien AlanChief Commercial Officer · Oct 26, 2026
35
PA
Perriman Damien AlanChief Commercial Officer
EXOZEXOZYMES INC.
Open-market sale
SELL
$19K
3,729 sh
Oct 12, 2026
Oct 26, 2026
traded Oct 12, 2026
+14d
SEC FORM 4

Evidence

23
PA
Perriman Damien AlanChief Commercial Officer
EXOZEXOZYMES INC.
Option exercise
M—
3,922 sh
Oct 9, 2026Oct 26, 2026
traded Oct 9, 2026
+17dSEC FORM 4

Evidence